Literature DB >> 21994261

Endogenous BDNF regulates inhibitory synaptic transmission in the ventromedial nucleus of the hypothalamus.

Young-Hwan Jo1.   

Abstract

Output from steroidogenic factor-1 (SF-1) neurons in the ventromedial nucleus of the hypothalamus (VMH) is anorexigenic. SF-1 neurons express brain-derived neurotrophic factor (BDNF) that contributes to the regulation of food intake and body weight. Here I show that regulation of GABAergic inputs onto SF-1 neurons by endogenous BDNF determines the anorexigenic outcome from the VMH. Single-cell RT-PCR analysis reveals that one-third of SF-1 neurons express BDNF and that only a subset of BDNF-expressing SF-1 neurons coexpresses the melanocortin receptor type 4. Whole cell patch-clamp analysis of SF-1 neurons in the VMH shows that exogenous BDNF significantly increases the frequency of spontaneous GABAergic inhibitory postsynaptic currents (sIPSCs). This enhancement of GABA drive readily decreases the excitability of SF-1 neurons. However, treatment with BDNF has no significant effect on the frequency of TTX-independent GABAergic IPSCs. Moreover, TrkB receptors are not localized at the postsynaptic sites of GABAergic synapses on SF-1 neurons as there is no change in the amplitude of miniature IPSCs in the presence of BDNF. Dual patch-clamp recordings in mouse hypothalamic slices reveal that stimulation of one SF-1 neuron induces an increase in sIPSC frequency onto the neighboring SF-1 neuron. More importantly, this effect is blocked by a tyrosine kinase inhibitor. Hence, this increased GABA drive onto SF-1 neurons may, in part, explain the cellular mechanisms that mediate the anorexigenic effects of BDNF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994261     DOI: 10.1152/jn.00353.2011

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  9 in total

1.  Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.

Authors:  Thomas H Meek; Miles E Matsen; Vincent Damian; Alex Cubelo; Streamson C Chua; Gregory J Morton
Journal:  Endocrinology       Date:  2014-08-19       Impact factor: 4.736

Review 2.  Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

Authors:  Rishabh Charan Choudhary; Xiaofeng Jia
Journal:  Ther Hypothermia Temp Manag       Date:  2017-05-03       Impact factor: 1.286

3.  Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat.

Authors:  Miguel López; Carlos Diéguez; Rubén Nogueiras
Journal:  Adipocyte       Date:  2015-01-07       Impact factor: 4.534

4.  Single-cell multiplex qPCR evidence for sex-dimorphic glutamate decarboxylase, estrogen receptor, and 5'-AMP-activated protein kinase alpha subunit mRNA expression by ventromedial hypothalamic nucleus GABAergic neurons.

Authors:  Md Haider Ali; Ayed A Alshamrani; Prabhat R Napit; Karen P Briski
Journal:  J Chem Neuroanat       Date:  2022-06-27       Impact factor: 3.097

Review 5.  The brain and brown fat.

Authors:  Cristina Contreras; Francisco Gonzalez; Johan Fernø; Carlos Diéguez; Kamal Rahmouni; Rubén Nogueiras; Miguel López
Journal:  Ann Med       Date:  2014-06-10       Impact factor: 4.709

6.  Apelin-13 enhances arcuate POMC neuron activity via inhibiting M-current.

Authors:  Dong Kun Lee; Jae Hoon Jeong; Seunghoon Oh; Young-Hwan Jo
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 7.  Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes.

Authors:  Seungah Lee; Dong Yun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-03-31

8.  The brain-liver connection between BDNF and glucose control.

Authors:  Young-Hwan Jo; Streamson C Chua
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

9.  Long-term increased carnitine palmitoyltransferase 1A expression in ventromedial hypotalamus causes hyperphagia and alters the hypothalamic lipidomic profile.

Authors:  Paula Mera; Joan Francesc Mir; Gemma Fabriàs; Josefina Casas; Ana S H Costa; Maria Ida Malandrino; José-Antonio Fernández-López; Xavier Remesar; Su Gao; Shigeru Chohnan; Maria Sol Rodríguez-Peña; Harald Petry; Guillermina Asins; Fausto G Hegardt; Laura Herrero; Dolors Serra
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.